PDCD1 and non-small cell lung carcinoma: Additionally, smoking habits could predict a more favourable response in patients with NSCLC treated with anti-PD-1 drugs, probably due to the increasing tumour mutational burden induced by carcinogens released by cigarette combustion [83].